Revenue - Schedule of GTN Product Revenue, Net (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024	Dec. 31, 2024
Gross To Net Sales Adjustment Rollforward [Roll Forward]
Balance as of April 1, 2025	$ 12,039	$ 13,161	$ 17,489	$ 11,337
GTN accruals for current period	5,924	5,617	11,979	12,121
Prior period adjustments	(241)	(791)	(773)	(1,064)
Credits, payments and reclassifications	(3,540)	(3,479)	(14,513)	(7,886)
Balance as of June 30, 2025	14,182	14,508	14,182	14,508
Gross To Net Sales Adjustment [Abstract]
Accounts receivable, net	1,844		1,844		$ 1,792
Other current and non-current liabilities	12,338		12,338		15,697
Gross to net sales adjustment	14,182	14,508	14,182	14,508	17,489
Discarded Drug Rebate
Gross To Net Sales Adjustment Rollforward [Roll Forward]
Balance as of April 1, 2025	9,672	9,393	15,103	7,391
GTN accruals for current period	2,020	1,858	3,969	3,904
Prior period adjustments	0	0	(200)	(44)
Credits, payments and reclassifications	0	0	(7,180)	0
Balance as of June 30, 2025	11,692	11,251	11,692	11,251
Gross To Net Sales Adjustment [Abstract]
Gross to net sales adjustment	11,692	11,251	11,692	11,251	15,103
Other Adjustments
Gross To Net Sales Adjustment Rollforward [Roll Forward]
Balance as of April 1, 2025	2,367	3,768	2,386	3,946
GTN accruals for current period	3,904	3,759	8,010	8,217
Prior period adjustments	(241)	(791)	(573)	(1,020)
Credits, payments and reclassifications	(3,540)	(3,479)	(7,333)	(7,886)
Balance as of June 30, 2025	2,490	3,257	2,490	3,257
Gross To Net Sales Adjustment [Abstract]
Gross to net sales adjustment	$ 2,490	$ 3,257	$ 2,490	$ 3,257	$ 2,386